NMP22® BladderChek® Test Case Studies. Value of a False Positive Test Result: Case Study #2 Diagnosis: 68 year old male non-smoker Presenting symptom:

Slides:



Advertisements
Similar presentations
UMDNJ N E W J E R S E Y M E D I C A L S C H O O L University of Medicine & Dentistry of New Jersey Francisco M. Dubocq, M.D. and Joseph V. DiTrolio, M.D.
Advertisements

Ten years of the CHD NSF Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health.
Promoting Quality Prevention Counseling Project: What have we learned? Spring 2005 Texas Tour Dallas, Fort Worth, Houston, Midland, Austin.
Proteinuria and Haematuria – an update Alex Heaton
Golan.O, Sperber.F, Shalmon.A, Weinstein.I, Gat.A
Transitional Cell Carcinoma of the Urinary Tract
Philippe GRENIER University Pierre et Marie Curie (UPMC),
2003 CDA Clinical Practice Guidelines
Bladder Cancer Immunotherapy: Progress and Current Limitations
Benign Prostatic Hyperplasia
Dr. Bipul Kumar Das (PGT) Dr. Kumud Pathak, M.D. Dr. P. Biswanath, A sso. Professor, Dept. of Paediatrics AMCH A Clinical Study of Tuberculosis in Children.
Source: Financial Times of London Global Banks 1999 – 2009 “Changing of the Guard”
CP Incidence of Cholangiocarcinoma Cumulative incidence of cholangiocarcinoma (%) Years since PSC diagnosis CP
Controversies in heart failure diagnosis
David J. Hass, MD Assistant Clinical Professor of Medicine Yale University School of Medicine Gastroenterology Center of Connecticut, P.C.
Jonathan A. Leighton, MD Mayo Clinic Arizona Great Debates and Updates in IBD San Francisco, CA March 2013 Small Bowel Evaluation.
Prostate cancer diagnosis today Mungai Ngugi. Introduction Prostate cancer remains a major problem in the world and particularly in black people who have.
Breast Cancer, A Common Problem in Sri Lanka
The Role of Urine cytology in the investigation of Haematuria? B Barrass Audit Meeting 17 th May 2006.
Haematuria and Urinary Tract Tumours
1 UTILITY OF NMP22 BLADDERCHEK POINT-OF- CARE ASSAY IN EVALUATION OF HEMATURIA: A MULTICENTER STUDY Giora Katz* M.D. Lakeshore Urology manitowoc WI, and.
Prostate Cancer Detection in Men with an Initial Diagnosis of Atypical small Acinar Proliferations Dr Charles Chabert The Wollongong Hospital.
Endoscopic diagnosis of upper-tract TCC – Correlating indications, investigations and histology Finch W, Shah N, Wiseman O Addenbrooke’s Hospital Cambridge.
Martina Rastovac Mentor: A. Žmegač Horvat. Actor Patrick Swayze died after a 20-month battle with pancreatic cancer. He was 57.Patrick Swayze.
Signs, Symptoms and Findings. EXAMPLES OF TYPES OF PHYSICAL PATHOLOGY Independent organismal continuant Portion of canonical body substance Pathological.
LOGO UPPER URINARY TRACT T.C.C. Presented by: Dr.HashimNaji R3.
FISH Analysis in Urothelial Cancer Michael Neat, Dr M Mason and Dr A Chandra.
Treatment Localized disease: Radical nephrectomy. Metstatic disease: Radiation therapy. Immunotherapy PROGNOSIS: stage % 5yrs survival stageII 60%
AJCC Staging Moments AJCC TNM Staging 7th Edition Lung Case #1 Contributors: Valerie W. Rusch, MD Memorial Sloan-Kettering Cancer Center, New York, New.
1 IMPROVED DETECTION AND SURVEILLANCE OF BLADDER CANCER USING A POINT-OF- CARE NMP22 ASSAY Giora Katz MD, Raoul Salup MD, And the NMP22 Clinical Investigation.
Female Cancer Fatima Reyadh Mrs. Timm 12A March 10, 2013.
بسم الله الرحمن الرحيم. Interpretation of urine cytology Nashwa Emara M.D.,phd ASS. Prof. Pathology.
USEFULNESS OF MRI IN THE DIAGNOSIS OF SALIVARY GLAND PATHOLOGIES
PANCREATIC CANCER.
Dr. Abdellatif Zayed Bladder Cancer.
Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay Barry Stein, M.D. G. Katz, M.D. NMP22.
Initial Diagnosis of Bladder Cancer Using a Point-of-Care Assay H. Barton Grossman, M.D. and the NMP22 Clinical Investigation Group.
Renal tumours Dr. Hawre Qadir Salih.
 Aggressive Angiomyxoma (AA) is a very rare tumor. It was first described in 1983 and since then only about 250 cases have been reported  Women.
Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis? Yair Lotan, Robert S. Svatek, Arthur I. Sagalowsky.
Cytologic and DNA- Cytometric Early Diagnosis of Oral Cancer Torsten W. Remmerbach, Horst Weidenbach, Natalja Pomjanski, Kristiane Knops, Stefanie Mathes,
1 Tumors of Urinary Tract. 2 Urinary Tract Neoplasm KidneyRenal Cell Carcinoma [ adult], Transitional cell carcinoma [ adult], Wilms Tumor [children]
Implications of lung cancer screening in the new millenia Andrew R. Haas, MD, PhD Assistant Professor of Medicine Section of Interventional Pulmonary and.
Cancer 101: A Cancer Education and Training Program for American Indians & Alaska Natives Cancer 101: A Cancer Education and Training Program for American.
By Dr. Abdelaty Shawky Assistant professor of pathology
University Hospitals Portage Medical Center. Portage County has one of the highest annual incidence rates of bladder cancer in the state of Ohio. According.
Cytologic Findings in Type 2 Cervical Carcinomas: Some Cervical Carcinomas are more Difficult to Prevent with Screening R. Marshall Austin MD,PhD Magee-Womens.
Hematuria Resident Lecture
Clinical History Patient presents with a palpable upper abdominal mass Patient states possible clinical history of abdominal hernia.
 Made of certain proteins.  Directs the timing and sequence of events in the cell cycle.  If something goes wrong, Cells lose control of cell cycle.
RENAL PARENCHYMA NEOPLASM ADENOCARCINOMA (RENAL CELL CARCINOMA). Adenocarcinoma of kidney represent about 3% of adult cancer Adenocarcinoma of kidney.
A 50 year old diabetic female presented with burning micturition associated with urinary frequency & suprapubic pain.
Carcinoma of the urinary bladder in a tertiary care setting in a developing country Farhana Badar, Ambreen Sattar, Fouzia Meerza, Noreen Irfan, Neelam.
Case 3 75 Yr male. pT1 TCC upper ureter. Smoker CKD stage 2 Diabetic Monday morning. Patient admitted for lap nephroureterectomy. Discuss procedure and.
Canadian Undergraduate Urology Curriculum (CanUUC): Hematuria
Module Leader: Louise Jones
Woo Cheal Cho MD1, Fabiola Balarezo, MD1
Cancer.
Chapter 14 Hepatic Tumors, Malignant 1
MSK system- 2nd yr medical students
EVALUATING THE EARLY EFFECTS OF TRU-CUT BIOPSY UNDER CT GUIDANCE IN PATIENTS WITH LUNG TUMOUR AT NATIONAL LUNG HOSPITAL. Dr. Phuong Ngoc Anh National Lung.
Low SI on axial T2-weighted images as a sign of malignancy.
Case 7.
SMK Aghamir MD endourologist TUMS
Clinical courses of patients.
A 53-year-old male patient with temporal lobe epilepsy (case 31).
Ill-defined margins as a sign of malignancy.
Classification tree with the selected characteristics.
MSK system- 2nd yr medical students
Presentation transcript:

NMP22® BladderChek® Test Case Studies

Value of a False Positive Test Result: Case Study #2 Diagnosis: 68 year old male non-smoker Presenting symptom: Hematuria Cystoscopy: Benign / Suspicious Cytology: Atypical / Suspicious NMP22 BladderChek: Positive Pathology: TCC T2aG3 1,331 patient, 23 site Clinical Study published in Grossman HB, et al. JAMA 293: (2005) Data on file at Matritech

Value of a False Positive Test Result: Case Study #3 Diagnosis: 68 year old male with H/O smoking Presenting symptom: Hematuria Cystoscopy: No abnormality Cytology:Malignant Cells NMP22 BladderChek: Positive Upper tract imaging T2G2 Ca of ureter Nephroureterectomy 1,331 patient, 23 site Clinical Study published in Grossman HB, et al. JAMA 293: (2005) Data on file at Matritech

Value of a False Positive Test Result: Case Study #1 Monitoring: 80 yr. old male 1993 Initial diagnosis: TCC Immunotherapy 2/14/02 – Cystoscopy: tumor / benign – Cytology: Suspicious / Atypical – NMP22 BladderChek: Positive Pathology: TCC Ta G2 668 patient, 23 site Clinical Study published in Grossman HB, et al. JAMA 295: (2006) Data on file at Matritech

Value of a False Negative Test Result: Case Study #1 Monitoring : 65 yr old male 2000 Initial diagnosis T1 9/2001 Immunotherapy 12/2001 – Cystoscopy: tumor-like growth – Cytology: Atypical – NMP22 BladderChek: Negative Pathology: benign disease / urethritis 668 patient, 23 site Clinical Study published in Grossman HB, et al. JAMA 295: (2006) Data on file at Matritech

Added Value when Cytology is Uninformative Case Study #1 Monitoring: 77 yr old male 1997 Initial diagnosis: TCC Ta Sep 2001 Immunotherapy Oct 2001 – Cystoscopy: tumor / cis – Cytology: Suspicious – NMP22 BladderChek: Positive Pathology: TCC T1 G3 668 patient, 23 site Clinical Study published in Grossman HB, et al. JAMA 295: (2006) Data on file at Matritech